Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Advisor to its Board and Chair of its R and D Committee
Read Article
News
2024
2023
Archive
Search news articles
June 6, 2019
“Meet the Man Who’s Talking On the Emperor of All Maladies: Cancer”
June 4, 2019
Bayer and Arvinas to Collaborate on Human PROTAC® Therapies and Launch a Separate Joint Venture to Develop Agricultural PROTAC® Applications
June 3, 2019
IND for NOUS-209, an “Off-The-Shelf” Neoantigen Cancer Vaccine, Cleared by FDA to Commence Clinical Development in MSI Solid Tumors
May 30, 2019
Scientist.com Partners With 5AM Ventures to Create an R&D Marketplace for Biotech Startups
May 29, 2019
Vor Biopharma Announces Publication of Proof-of-Concept Study of its Lead Program in the Scientific Journal PNAS
May 29, 2019
Arvinas Receives Fast Track Designation For Its Targeted Protein Degrader ARV-110 As A Treatment For Men With Metastatic Castration-Resistant Prostate Cancer
May 24, 2019
IDEAYA Announces Pricing of Initial Public Offering
May 17, 2019
CinCor Pharma In-Licenses Aldosterone Synthase Inhibitor, CIN-107, and Closes $50 Million Series A Financing
May 17, 2019
Homology Medicines Announces FDA Fast Track Designation for HMI-102 Gene Therapy Development Candidate for Adults with PKU
May 17, 2019
Pear Therapeutics Initiates Feasibility Study to Treat Depressive Symptoms in People with Multiple Sclerosis
« Previous Page
1
…
52
53
54
55
56
…
103